Tech Company Financing Transactions
Mission Bio Funding Round
Agilent Technologies, Cota Capital and Lam Research participated in a $30 million Series B funding round for Mission Bio. The round was announced on 12/14/2018.
Transaction Overview
Company Name
Announced On
12/14/2018
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series B
Investors
Proceeds Purpose
The funds will scale its unique single-cell DNA technology, the Tapestri Platform, by expanding the market for blood cancer research, while at the same time broadening its scope to CRISPR applications and extending into global markets.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6000 Shoreline Ct. 104
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Mission Bio provides tools for the study of cellular heterogeneity in human health and life science research. Our approach relies on proprietary microfluidic droplet technology to deliver rapid and cost-effective solutions for molecular analysis of single cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Charlie Silver
Chief Financial Officer
Marcel Roche
Chief Technical Officer
Nigel Beard
Vice President
Anup Parikh
VP - Bus. Development
Darrin Crisitello
VP - Bus. Development
Harsha Kavuri
VP - Engineering
Adam Sciambi
VP - Human Resources
Sharon Hebrok
VP - Marketing
Hannah Viernes
VP - Product Management
Anjali Pradhan
VP - R & D
David Ruff
VP - Sales
George Kopitas
Browse more venture capital transactions:
Prev: 12/14/2018: Wisdo venture capital transaction
Next: 12/14/2018: Vyng venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs